Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun 17:9:676296.
doi: 10.3389/fped.2021.676296. eCollection 2021.

Emergent Pneumonia in Children

Affiliations
Review

Emergent Pneumonia in Children

Cecilia Perret et al. Front Pediatr. .

Abstract

In recent decades there have been multiple pathogens, viruses and bacteria, which have emerged as causal agents of pneumonia affecting adults, albeit less frequently, to children. For the purposes of this article we have classified emerging pathogens as follows: True emerging, to pathogens identified for the very first time affecting human population (SARS-CoV-1, SARS-CoV-2, MERS-CoV, avian influenza, and hantavirus); Re-emerging, to known pathogens which circulation was controlled once, but they have reappeared (measles, tuberculosis, antimicrobial resistant bacteria such as CA-MRSA, Mycoplasma pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and new serotypes of post-vaccine pneumococcal); and finally, those that we have called old known with new presentations, including common pathogens that, in particular condition, have changed their form of presentation (rhinovirus, and non-SARS coronavirus). We will review for each of them their epidemiology, forms of presentation, therapy, and prognosis in children compared to the adult with the aim of being able to recognize them to establish appropriate therapy, prognostics, and effective control measures.

Keywords: COVID - 19; children; emerging respiratory pathogens; pneumonia - clinical features and management; re-emerging respiratory pathogens.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Timeline of epidemics and pandemics involving the lower respiratory tract during the last two decades.
Figure 2
Figure 2
Number of cases of Severe Acute Respiratory Syndrome (SARS) caused by emerging coronaviruses worldwide from 2003 to 2020. SARS (purple), MERS (red), and COVID-19 (yellow) cases until December 21, 2020. Size of circles is proportional to the number of cases (range: 0–23,886,000 cases).
Figure 3
Figure 3
Numbers of New World Hantaviruses confirmed cases in the Americas. Size of circles is proportional to the number of cases (range 6–2032 cases).
Figure 4
Figure 4
Chest X-ray showing diffuse interstitial and alveolar infiltrates in a newborn with Hantavirus infection.

References

    1. Budnik I, Ferrés M, Pardo T, Edwards J, Labarca G, Reyes F, et al. . Contribution of molecular biology in the diagnosis of acute respiratory infections. Rev Chil Enferm Respir. (2016) 32:224–3. 10.4067/S0717-73482016000400003 - DOI
    1. Chen Z, Boon SS, Wang MH, Chan RWY, Chan PKS. Genomic and evolutionary comparison between SARS-CoV-2 and other human coronaviruses. J Virol Methods. (2020) 289:114032. 10.1016/j.jviromet.2020.114032 - DOI - PMC - PubMed
    1. Peiris JS, Lai ST, Poon LL, Guan Y, Yam LY, Lim W, et al. . Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet. (2003) 361:1319–25. 10.1016/S0140-6736(03)13077-2 - DOI - PMC - PubMed
    1. Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, et al. . A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. (2003) 348:1953–66. 10.1056/NEJMoa030781 - DOI - PubMed
    1. Leung TF, Wong GWK, Hon KLE, Fok TF. Severe acute respiratory syndrome (SARS) in children: epidemiology, presentation and management. Paediatr Respir Rev. (2003) 4:334–9. 10.1016/S1526-0542(03)00088-5 - DOI - PMC - PubMed